Fujian Aonong Biological Technology Group Incorporation Second Quarter 2024 Earnings: CN¥0.28 loss per share (vs CN¥0.71 loss in 2Q 2023)

Simply Wall St · 09/01 00:20

Fujian Aonong Biological Technology Group Incorporation (SHSE:603363) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥2.25b (down 57% from 2Q 2023).
  • Net loss: CN¥248.0m (loss narrowed by 61% from 2Q 2023).
  • CN¥0.28 loss per share (improved from CN¥0.71 loss in 2Q 2023).
earnings-and-revenue-growth
SHSE:603363 Earnings and Revenue Growth September 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Fujian Aonong Biological Technology Group Incorporation Earnings Insights

Looking ahead, revenue is forecast to grow 45% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Food industry in China.

Performance of the Chinese Food industry.

The company's shares are up 3.4% from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with Fujian Aonong Biological Technology Group Incorporation.